Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Ruggiero

Showing results (31-40 of 134) with videos related to

Pageof 14
Sort By:
Journal of Cosmetic Dermatology|August 11, 2022
Teledermatology in the management of hidradenitis suppurativa: Should we improve this service?Angelo Ruggiero, Claudio Marasca, Gabriella Fabbrocini, et al.
Dermatologic Therapy|June 16, 2020
Teledermatology and chronic skin diseases: Real life experience in a Southern Italian Dermatologic CentreAlessia Villani, Matteo Megna, Massimiliano Scalvenzi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 22, 2022
Reply to 'Nail psoriasis: A rare mRNA COVID-19 vaccine reaction' by Lamberti A et alAngelo Ruggiero, Luca Potestio, Teresa Battista, et al.
Clinical and Experimental Dermatology|June 21, 2022
Management of patients with hidradenitis suppurativa during COVID-19 vaccination: an experience from southern Italy. Comment on: 'Evaluating the safety and efficacy of COVID-19 vaccination in patients with hidradenitis suppurativa'Fabrizio Martora, Claudio Marasca, Teresa Battista, et al.
Skin Appendage Disorders|December 14, 2020
Hidradenitis Suppurativa in a Patient Affected by Mayer-Rokitansky-Küster-Hauser Syndrome: Insight into the Role of Hormones in HSAngelo Ruggiero, Gabriella Fabbrocini, Matteo Megna, et al.
Dermatologic Therapy|June 28, 2022
Ixekizumab and brodalumab indirect comparison in the treatment of moderate to severe psoriasis: Results from an Italian single-center retrospective study in a real-life settingMatteo Megna, Luca Potestio, Elisa Camela, et al.
Dermatologic Therapy|October 31, 2020
New emergent therapies for atopic dermatitis: A review of safety profile with respect to female fertility, pregnancy, and breastfeedingMaddalena Napolitano, Angelo Ruggiero, Giuseppina Fontanella, et al.
Psoriasis (Auckland, N.Z.)|June 16, 2022
Bimekizumab for the Treatment of Psoriasis: A Review of the Current KnowledgeAngelo Ruggiero, Luca Potestio, Elisa Camela, et al.
Journal of the American Academy of Dermatology|August 10, 2022
Reply to "Routine rescreening for latent tuberculosis has low utility in patients with chronic immune-mediated inflammatory diseases treated with biologics: A single-center, retrospective cohort study"Angelo Ruggiero, Luca Potestio, Elisa Camela, et al.
Expert Opinion on Biological Therapy|August 15, 2022
New frontiers in personalized medicine in psoriasisElisa Camela, Luca Potestio, Gabriella Fabbrocini, et al.
Pageof 14

Showing results (31-40 of 134) with videos related to

Sort By:
Pageof 14
Journal of Cosmetic Dermatology|August 11, 2022
Teledermatology in the management of hidradenitis suppurativa: Should we improve this service?Angelo Ruggiero, Claudio Marasca, Gabriella Fabbrocini, et al.
Dermatologic Therapy|June 16, 2020
Teledermatology and chronic skin diseases: Real life experience in a Southern Italian Dermatologic CentreAlessia Villani, Matteo Megna, Massimiliano Scalvenzi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 22, 2022
Reply to 'Nail psoriasis: A rare mRNA COVID-19 vaccine reaction' by Lamberti A et alAngelo Ruggiero, Luca Potestio, Teresa Battista, et al.
Clinical and Experimental Dermatology|June 21, 2022
Management of patients with hidradenitis suppurativa during COVID-19 vaccination: an experience from southern Italy. Comment on: 'Evaluating the safety and efficacy of COVID-19 vaccination in patients with hidradenitis suppurativa'Fabrizio Martora, Claudio Marasca, Teresa Battista, et al.
Skin Appendage Disorders|December 14, 2020
Hidradenitis Suppurativa in a Patient Affected by Mayer-Rokitansky-Küster-Hauser Syndrome: Insight into the Role of Hormones in HSAngelo Ruggiero, Gabriella Fabbrocini, Matteo Megna, et al.
Dermatologic Therapy|June 28, 2022
Ixekizumab and brodalumab indirect comparison in the treatment of moderate to severe psoriasis: Results from an Italian single-center retrospective study in a real-life settingMatteo Megna, Luca Potestio, Elisa Camela, et al.
Dermatologic Therapy|October 31, 2020
New emergent therapies for atopic dermatitis: A review of safety profile with respect to female fertility, pregnancy, and breastfeedingMaddalena Napolitano, Angelo Ruggiero, Giuseppina Fontanella, et al.
Psoriasis (Auckland, N.Z.)|June 16, 2022
Bimekizumab for the Treatment of Psoriasis: A Review of the Current KnowledgeAngelo Ruggiero, Luca Potestio, Elisa Camela, et al.
Journal of the American Academy of Dermatology|August 10, 2022
Reply to "Routine rescreening for latent tuberculosis has low utility in patients with chronic immune-mediated inflammatory diseases treated with biologics: A single-center, retrospective cohort study"Angelo Ruggiero, Luca Potestio, Elisa Camela, et al.
Expert Opinion on Biological Therapy|August 15, 2022
New frontiers in personalized medicine in psoriasisElisa Camela, Luca Potestio, Gabriella Fabbrocini, et al.
Pageof 14